Molnupiravir, also known by its brand name Lagevrio, represents a important advancement in the fight against the virus. This oral antiviral drug works by introducing errors into the virus's genetic sequence, effectively stopping its duplication and spread within the patient. While first data suggested a considerable reduction in severe illness and